Conmy Tablets 2mg

Country: Malasía

Tungumál: enska

Heimild: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Virkt innihaldsefni:

TERAZOSIN HCL DIHYDRATE

Fáanlegur frá:

SUNWARD PHARMACEUTICAL SDN. BHD.

INN (Alþjóðlegt nafn):

TERAZOSIN HCL DIHYDRATE

Einingar í pakka:

30 Tablets; 100 Tablets

Framleitt af:

TAIWAN BIOTECH CO., LTD.

Upplýsingar fylgiseðill

CONMY TABLETS
Terazosin Hydrochloride (2mg) 1
_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1. What Conmy Tablets 2mg is used for
2. How Conmy Tablets 2mg works
3. Before you use Conmy Tablets 2mg
4. How to use Conmy Tablets 2mg
5. While you are using it
6. Side effects
7. Storage and Disposal of Conmy Tablets 2mg
8. Product Description
9. Manufacturer and Product Registration
Holder
10. Date of revision
WHAT CONMY TABLETS 2MG IS USED FOR
It is used as treatment to control high blood
pressure and to improve urination in men due
to enlargement of prostate gland or known as
symptomatic
benign
prostatic
hyperplasia
(BPH).
HOW CONMY TABLETS 2MG WORKS
Terazosin hydrochloride relax the muscles in
prostate and bladder neck leads to improve-
ment in urine flow.
BEFORE YOU USE CONMY TABLETS 2MG
_- When you must not use it _
Do not take Conmy Tablets 2mg if you:-

have
heart
failure
due
to
mechanical
obstruction.

are
hypersensitivity
to
Terazosin
hydro-
chloride or any ingredients listed at the end
of this leaflet.
_- Before you start to use it _
Talk to your doctor before taking Conmy
Tablets 2mg, if you have:

low blood pressure
_Pregnancy and breastfeeding _
You should check with your doctor if you are
pregnant
or
think
you
may
be
pregnant,
planning to become pregnant or if you are
breastfeeding.
The
content
and
effects
of
Terazosin hydrochloride during breastfeeding
are unknown.
_Children _
Safety and effectiveness in children have not
been determined.
_- Taking other medicines _
There are few medicines which may interact
with Conmy Tablets 2mg. It is important to
tell your doctor or pharmacist about all the
medicines that you are taking, including those
obtained without doctor’s prescription.
You should talk to your doctor or pharmacist
if you are taking:-

medicines
used
for
pain
killer/anti-
inflammatory
(such
as
acetaminophen,
aspirin, codeine, ibuprofen, indomethacin).

medicines
contains
control
of
high
blood
pressure
agents
(calcium
channel
blocker
such as verapamil

Vara einkenni

CONMY TABLETS 2MG
Terazosin hydrochloride dihydrate 2.37mg equivalent to Terazosin 2mg
DESCRIPTION
It is a orange, round, flat tablet, a " BH “is scored on one side
and “S”on the other side.
2
COMPOSITION
Each tablet contains Terazosin hydrochloride dihydrate 2.37mg
equivalent to Terazosin 2mg.
MODE OF ACTION
_BENIGN PROSTATIC HYPERPLASIA (BPH):_
The symptoms associated with BPH are related to bladder outlet
obstruction, which is comprised of two underlying components: a static
component and a dynamic component. The static component is a
consequence of an increase in prostate size. Over time, the prostate
will continue to enlarge. However, clinical studies have demonstrated
that the size of the prostate does not correlate with the severity of
BPH symptoms or the degree of urinary obstruction. The dynamic
component is a function of an increase in smooth muscle tone in the
prostate and bladder neck, leading to constriction of the bladder
outlet. Smooth muscle tone is mediated by sympathetic nervous stimula-
tion of alpha-l adrenoceptors, which are abundant in the prostate,
prostatic capsule and bladder neck. The reduction in symptoms and
improvement in urine flow rates following administration of terazosin
is related to relaxation of smooth muscle produced by blockade of
alpha-l adrenoceptors in the bladder neck and prostate. Because there
are relatively few alpha-l adrenoceptors in the bladder body,
terazosin is able to reduce the bladder outlet obstruction without
affecting bladder contractility.
SUMMARY OF PHARMACODYNAMICS AND PHARMACOKINETICS
Terazosin is rapidly and almost completely absorbed from the
gastro-intestinal tract after oral administration; the bioavailability
is reported
to be about 90%. It is metabolized in the liver; one of the
metabolites is report to posses antihypertensive activity. The
half-life in plasma
is approximately 12 hours. It is excreted in faeces via the bile and
in the urine, as unchanged drug and metabolites. Terazosin is to 90 to
94% protein bound.
INDICATIONS
Terazosin hyd